2018
-
Outbreak of a deadly swine fever could trigger global heparin shortage
Heparin, one of the world’s most critical heart medications, could soon run in short supply due to an outbreak of African swine fever that’s wiped out nearly a quarter of the world’s pigs.
11/13/2019 -
Mylan hit with warning letter for valsartan manufacturing
The FDA sent a Mylan facility in India a warning letting for its manufacturing of APIs related to the widespread recall of blood pressure medications.
11/13/2019 -
Sandoz scoops up Aspen operations and assets in Japan for $330 million
According to the Novartis subsidiary, this acquisition reinforces its strategy to focus on Japan.
11/12/2019 -
Lupin offloads Japanese subsidiary for $526 million
The company's subsidiary Nanomi B.V. will divest its entire 99.82% stake to private equity fund Unison, which has experience in the healthcare sector.
11/12/2019 -
Lonza CEO makes sudden, surprise departure
Lonza investors were reportedly taken aback this week by the surprise announcement that the company’s CEO is planning to step down.
11/12/2019 -
AZ lupus drug hits the mark in late-stage study
AstraZeneca reported positive results this week from a late-stage lupus study.
11/12/2019 -
FDA hands 3rd denial to Lipocine testosterone med
The third time was not the charm for Lipocine’s male sex hormone treatment.
11/11/2019 -
Roche closer to breaking into lucrative SMA market with positive trial results
Positive trial results for an oral drug to treat spinal muscular atrophy (SMA) are bringing Roche one step closer to breaking into the high-cost treatment area.
11/11/2019 -
Pharma in review: trending stories 11/8/19
Most popular Pharma Manufacturing stories from the past seven days.
11/07/2019 -
Purdue shielded from litigation until April
A U.S. bankruptcy judge will approve an order that will extend a stay on more than 2,600 lawsuits that accuse the company and its owners of fueling the opioid crisis.
11/07/2019 -
Aurobindo-Sandoz deal pushed back as FTC seeks more info
The deal, originally announced back in September 2018, will not be closed until February 2020 at the earliest.
11/07/2019 -
Takeda sells portfolio of drugs for $660 million to German company
The German Stada will acquire a portfolio of approximately 20 selected OTC and prescription pharmaceutical products in Russia, Georgia and CIS countries
11/06/2019 -
AstraZeneca invests $1 billion in China
The British drugmaker is launching a fund with China International Capital Corporation and will also begin distributing Sun Pharma cancer drugs in China
11/06/2019 -
Novartis finally wins US approval for its generic Neulasta
The drugmaker's biosimilar Ziextenzo was originally rejected by the FDA in 2016
11/05/2019 -
Thermo Fisher invests $24 million in biologics site in Scotland
The site expansion in Inchinnan, which aims to add large-volume liquid manufacturing capacity for cell culture media, is expected to be completed by June 2021.
11/05/2019 -
FDA says ranitidine no more dangerous than ‘smoked meats’
Since all the hoopla surrounding ranitidine began, the FDA has been cautious in giving a final word on how dangerous the levels of NDMA in the drug could be.
11/05/2019 -
China OKs first new drug for Alzheimer’s in 17 years
China’s regulatory authority has approved a new treatment for Alzheimer’s based on seaweed.
11/04/2019 -
J&J says recalled talc had no asbestos, negating its own expert
Johnson & Johnson said that new testing of the recently recalled batch of baby powder did not show any traces of asbestos.
11/03/2019 -
Trump nominates new FDA commish as interim deadline expires
President Trump formally announced his intention to nominate Dr. Stephen M. Hahn, a top executive at The University of Texas M.D. Anderson Cancer Center, to be the next commissioner of the U.S. FDA.
11/03/2019 -
Sanofi settles lawsuit with former Genzyme shareholders
Sanofi has agreed to a $315 million payout in an aging lawsuit alleging that the drugmaker failed to use "diligent efforts" to advance development of a former Genezyme multiple sclerosis drug that would have resulted in payouts to shareholders.
11/01/2019